ttp889
Small moleculeexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2005 (NCT00119457)
Timeline
Indications
Mechanism of action
- Coagulation factor IXINHIBITOR
F9 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mdt-637
- mdt-637
- ttp889
- ttp889
- ttp889
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01556607 | Phase 1 | Mar 1, 2012 | MicroDose, WCCT Global |
| NCT01489306 | Phase 1 | Dec 1, 2011 | MicroDose |
| NCT01355016 | Phase 1 | Sep 1, 2011 | MicroDose |
| NCT00909298 | Phase 2 | Jun 1, 2009 | Columbia University, Icahn School of Medicine at Mount Sinai, National Heart, Lung, and Blood Institute (NHLBI), vTv Therapeutics |
| NCT00119457 | Phase 2 | Jan 1, 2005 | University of Gothenburg, vTv Therapeutics |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MicroDose | For profit | 3 | 3 | 1 | 2011 |
| vTv Therapeutics | For profit | 2 | 2 | 1 | 2005 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 0 | 1 | 2009 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2009 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2005 |
| WCCT Global | For profit | 1 | 0 | 1 | 2012 |
7 organizations
Page 1 / 1